Clinical Trial Update: Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update indicates GS-1427 is being studied for moderately to severely active ulcerative colitis and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GS-1427

Snippet

Sponsor: Gilead Sciences | Conditions: Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING